US Patent 11396550 Methods of treating comprising administering anti-OX40L antibodies
Patent 11396550 was granted and assigned to Kymab on July, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11396550 Methods of treating comprising administering anti-OX40L antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
